Leder Benjamin Md Google Scholar David Northern Arizona Healthcare
Claim credits plan your learning browse journals and articles view sessions recordings Google scholar provides a simple way to broadly search for scholarly literature. It is unknown if switching from one therapy to another.
Benjamin Leder, MD Endocrine Society
Leder, md, department of medicine, endocrine unit, massachusetts general hospital, harvard university, 55 fruit st, boston, ma 02114,. Benjamin z leder's 22 research works with 189 citations and 1,637 reads, including: Orcid record for benjamin leder.
Also Read:
The ones marked * may be different from the article in the profile.
Discontinuing teriparatide and denosumab, however, results in rapidly declining bone mineral density. Search across a wide variety of disciplines and sources: Benjamin leder is an professor of medicine at harvard medical school and medical director of the massachusetts general hospital endocrine associates. Orcid provides an identifier for individuals to use with their name as they engage in research, scholarship, and innovation activities.
This cited by count includes citations to the following articles in scholar. Bzleder@partners.org search for more papers. Benjamin leder, md, mgh endocine unit 50 bloosm street, thr‐1001 boston, ma 02114. Discontinuing teriparatide and denosumab, two of our most potent agents, results in rapidly declining bone mineral density (bmd).
Articles, theses, books, abstracts and court opinions.
Completely revised and updated, and utilizing the most current evidence and practice guidelines for the treatment of osteoporosis, this comprehensive third edition discusses the basic aspects. Benjamin leder | cited by 6,723 | of partners healthcare, massachusetts | read 111 publications | contact benjamin leder
